Hantz Financial Services, Inc. United Therapeutics Corp Transaction History
Hantz Financial Services, Inc.
- $6.19 Billion
- Q2 2025
A detailed history of Hantz Financial Services, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 246 shares of UTHR stock, worth $110,436. This represents 0.0% of its overall portfolio holdings.
Number of Shares
246
Previous 12
1950.0%
Holding current value
$110,436
Previous $4,000
1675.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
746Shares Held
44.1MCall Options Held
340KPut Options Held
318K-
Black Rock Inc. New York, NY5.47MShares$2.46 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$2 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$1.06 Billion12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$973 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$951 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $20.4B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...